Skip to content

Funding Opportunities, November 8

Limited Submission Opportunities

Starting this month, Limited Submission Opportunity announcements will have a new look! Click here to sign up for the Limited Submissions mailing list to receive funding opportunity announcements.

Contact Hannah Schmidt (hschmidt@utk.edu) if you have any questions.

NIH Opportunities

Join the UT NIH Research Community by contacting Jennifer Webster (jwebster@utk.edu) and start receiving the weekly NIH Digest.

  • NIH Standard Deadlines for Investigator-Initiated Research Projects
  • NIH Academic Research Enhancement Award (R15 Clinical Trial Required) (PA-18-343)
  • NIH Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01 Clinical Trial Optional) (PA-18-284)
  • NIH Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21 Clinical Trial Optional) (PA-18-285)
  • NIH Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) (PA-18-001)
  • NIH Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Optional) (PAR-18-112)

  • NIH Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Optional) (PA-18-010)
  • NIH Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) (PAR-18-007)
  • NIH Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) (PAR-18-017)
  • NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required) (PA-18-344)
  • NIH Research Project Grant (Parent R01 Clinical Trial Required) (PA-18-345)
  • NIH Understanding Factors in Infancy and Early Childhood (Birth to 24 months) That Influence Obesity Development (R01 Clinical Trial Optional) (PA-18-032)
  • NCCIH Center of Excellence for Research on Complementary and Integrative Health (P01 Clinical Trial Optional) (PAR-18-113)
  • NCCIH Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R33 Clinical Trial Required) (PAR-18-115)
  • NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) (PAR-18-118)
  • NCCIH Phased Innovation Award for Mechanistic Studies to Optimize Mind and Body Interventions in NCCIH High Priority Research Topics (R61/R33 Clinical Trial Required) (PAR-18-114)
  • NCI Examination of Survivorship Care Planning Efficacy and Impact (R01 Clinical Trial Optional) (PA-18-002)
  • NCI Examination of Survivorship Care Planning Efficacy and Impact (R21 Clinical Trial Optional) (PA-18-012)
  • NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 – Clinical Trials Required) (PAR-18-336)
  • NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 – No Independent Clinical Trials) (PAR-18-337)
  • NCI Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) (PA-18-004)
  • NCI Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional) (PA-18-014)
  • NCI Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) (PAR-18-006)
  • NCI Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) (PAR-18-016)
  • NCI National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) (PAR-18-290)
  • NCI Research Specialist (Laboratory-based Scientist) Award (R50) (PAR-18-341)
  • NCI Research Specialist (Core-based Scientist) Award (R50) (PAR-18-342)
  • NCI / NHLBI Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) (PA-18-013)
  • NCI / NHLBI Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) (PA-18-003)
  • NCI / NIA Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional) (PA-18-005)
  • NCI / NIA Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional) (PA-18-015)
  • NCI / NIBIB / NIDCD Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) Clinical Trial Optional (PA-18-339)
  • NCI / NIDDK Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional) (PAR-18-009)
  • NHLBI / NIMH Revision Applications for Validation of Mobile/Wireless Health Tools for Measurement and Intervention (R01) (Clinical Trials Not Allowed) (PA-18-338)
  • NIA Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33 Clinical Trial Optional) (PAR-18-181)
  • NIA Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01 Clinical Trial Optional) (PAR-18-029)
  • NIA Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional) (PAR-18-296)
  • NIA Phase III Clinical Trials for the Spectrum of Alzheimer’s Disease and Age-related Cognitive Decline (R01 Clinical Trial Required) (PAR-18-028)
  • NIA Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research (R01 Clinical Trial Optional) (PAR-18-026)
  • NIA Program Project Applications (P01 Clinical Trial Optional) (PAR-18-297)
  • NIA Revision and Resubmission Program Project Applications (P01 Clinical Trial Optional) (PAR-18-030)
  • NIA / NCI Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional) (PA-18-025)
  • NIA / NINR Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R01 Clinical Trial Optional) (PAS-18-030)
  • NIA / NINR Pilot Clinical Trials for the Spectrum of Alzheimers Disease and Age-related Cognitive Decline (R01 Clinical Trial Optional) (PAR-18-175)
  • NIAAA Alcohol Impairment of Immune Function, Host Defense and Tissue Homeostasis (R01 Clinical Trial Optional) (PA-18-191)
  • NIAAA Increasing the Use of Medications for the Treatment of Alcohol Use Disorders (R01 Clinical Trial Optional) (PAR-18-196)
  • NIAAA Program for Extramural/Intramural Alcohol Research Collaborations (U01 Clinical Trial Optional) (PAR-18-195)
  • NIAID Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11-Clinical Trial Not Allowed) (PAR-18-335)
  • NIBIB Biomedical Technology Resource Centers (P41 Clinical Trials Optional) (PAR-18-205)
  • NICHD Advancing Understanding, Prevention and Management of Infections Transmitted from Women to their Infants (R21 Clinical Trial Optional) (PA-18-092)
  • NICHD Advancing Understanding, Prevention, and Management of Infections Transmitted from Women to their Infants (R01 Clinical Trial Optional) (PA-18-031)
  • NICHD Characterization of the Adolescent Reproductive Transition (R21 Clinical Trial Optional) (PA-18-045)
  • NICHD Characterization of the Adolescent Reproductive Transition (R03 Clinical Trial Optional) (PA-18-046)
  • NICHD Characterization of the Adolescent Reproductive Transition (R01 Clinical Trial Optional) (PA-18-033)
  • NICHD Outcome Measures for Use in Treatment Trials of Individuals with Intellectual and Developmental Disabilities (R01- Clinical Trial Optional) (PAR-18-039)
  • NICHD Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R01 Clinical Trial Optional) (PA-18-038)
  • NICHD Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R21 Clinical Trial Optional) (PA-18-043)
  • NICHD Safety and Outcome Measures of Pain Medications Used in Children and Pregnant Women (R03 Clinical Trial Optional) (PA-18-044)
  • NICHD Studies at Periviable Gestation (R01 Clinical Trial Optional) (PA-18-036)
  • NICHD Studies at Periviable Gestation (R03 Clinical Trial Optional) (PA-18-053)
  • NICHD Studies at Periviable Gestation (R21 Clinical Trial Optional) (PA-18-097)

  • NICHD / NIDDK Natural History of Disorders Identifiable by Screening of Newborns (R01 Clinical Trial Optional) (PAR-18-090)
  • NIDA Application of Big Data Analytics to Drug Abuse Research (R01 Clinical Trial Optional) (PA-18-057)
  • NIDA Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R21 Clinical Trial Optional) (PA-18-075)
  • NIDA Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders (R01 Clinical Trial Optional) (PA-18-056)
  • NIDA HIV/AIDS High Priority Drug Abuse Research (R01 Clinical Trial Optional) (PAS-18-063)
  • NIDA Neuroscience Research on Drug Abuse (R01 Clinical Trial Optional) (PA-18-060)
  • NIDA Neuroscience Research on Drug Abuse (R21 Clinical Trial Optional) (PA-18-078)
  • NIDA Prescription Drug Abuse (R01 Clinical Trial Optional) (PA-18-058)
  • NIDA Prescription Drug Abuse (R21 Clinical Trial Optional) (PA-18-076)
  • NIDA / NCI / NIAAA Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) (PAR-18-062)
  • NIDA / NIA Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R01 Clinical Trial Optional) (PA-18-061)
  • NIDA / NIA Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R21 Clinical Trial Optional) (PA-18-079)
  • NIDA / NIA Marijuana, Prescription Opioid, or Prescription Benzodiazepine Drug Use Among Older Adults (R03 Clinical Trial Optional) (PA-18-080)
  • NIDA / NIAAA Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) (PA-18-055)
  • NIDA / NIAAA Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional) (PA-18-073)
  • NIDA / NIAAA Behavioral and Integrative Treatment Development Program (R03 Clinical Trial Optional) (PA-18-074)
  • NIDCD Improving Outcomes for Disorders of Human Communication (R01 Clinical Trial Optional) (PA-18-287)
  • NIDCD Improving Outcomes for Disorders of Human Communication (R21 Clinical Trial Optional) (PA-18-288)
  • NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35)- Clinical Trial Not Allowed (RFA-DE-18-011)
  • NIDDK Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01 Clinical Trial Optional) (PAR-18-042)
  • NIDDK George M. O’Brien Urology Cooperative Research Centers Program (U54-Clinical Trial Optional) (RFA-DK-17-013)
  • NIDDK Multidisciplinary Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional) (RFA-DK-17-012)
  • NIDDK Program Projects (P01 Clinical Trial Optional) (PAR-18-012)
  • NIDDK / NCCIH / NCI Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional) (PA-18-034)
  • NIEHS / NINR Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional) (PA-18-260)
  • NIMH / NIDA Mobile and Connected Health Interventions to Improve Care Continuum and Health Outcomes among Youth with HIV (R34) (RFA-MH-18-605)
  • NIMH / NIDA / NIMHD Mobile and Connected Health Interventions to Improve Care Continuum and Health Outcomes among Youth with HIV (R01) (RFA-MH-18-606)
  • NINR Functional Wellness in HIV: Maximizing the Treatment Cascade (R01 Clinical Trial Optional) (PA-18-136)
  • NINR Functional Wellness in HIV: Maximizing the Treatment Cascade (R21 Clinical Trial Optional) (PA-18-154)
  • NINR Maternal Nutrition and Pre-pregnancy Obesity: Effects on Mothers, Infants and Children (R01 Clinical Trial Optional) (PA-18-135)
  • NINR / NIA Prevention Research in Mid-Life Adults (R01 Clinical Trial Optional) (PA-18-134)
  • NINR / NIA Prevention Research in Mid-Life Adults (R21 Clinical Trial Optional) (PA-18-153)
  • RELATED SPONSOR: FDA Flexible Funding Model – Infrastructure Development and Maintenance for State Manufactured Food Regulatory Programs (U18) (RFA-FD-18-001)

NSF Opportunities

Please contact Sharon Pound (spound@utk.edu) regarding your interest in NSF opportunities.

  • Dynamics of Coupled Natural and Human Systems (CNH) NSF 18-503
  • Enabling Discovery through GEnomic Tools (EDGE) NSF 18-506
  • International Research Experiences for Students (IRES) NSF 18-505
  • Campus Cyberinfrastructure (CC*) NSF 18-508
  • Research Coordination Networks in Undergraduate Biology Education (RCN-UBE) NSF 18-510
  • Dimensions of Biodiversity FY2018 NSF 18-512

NSF Dear Colleague Letters

  • Joint NSF/ENG and AFOSR Funding Opportunity: Supporting Fundamental Research in the Quantitative Representation of Microstructures (QRM) NSF 18-018
  • Principles for the Design of Digital Science, Technology, Engineering, and Mathematics (STEM) Learning Environments NSF 18-017

The flagship campus of the University of Tennessee System and partner in the Tennessee Transfer Pathway.

Report an accessibility barrier